Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/1996
03/27/1996EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors
03/27/1996EP0702716A1 Ribozyme gene therapy for hiv infection and aids
03/27/1996EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
03/27/1996EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
03/27/1996EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
03/27/1996CN1119459A Process for preparing cancer vaccines
03/26/1996US5502273 Biosynthesis of polylactones, expression of genes from alcaligenes
03/26/1996US5502271 Maize resistant to aryloxyphenoxyalkanecarboxylic acid herbicides
03/26/1996US5502167 CDR grafted humanised chimeric T-cell antibodies
03/26/1996US5502034 Methods for producing thrombin
03/26/1996US5501988 Cancer detection
03/26/1996US5501979 Herpes simplex virus type I expression vector
03/26/1996US5501972 Method of producing embryogenic callus of Norway spruce (Picea abies and regenerating plantlets therefrom
03/26/1996US5501971 Method and apparatus for anchorage and suspension cell culture
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501959 Microbiocides and conversion of resazurin to resorfurin
03/26/1996US5501853 Peptide plasminogen activators
03/21/1996WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases
03/21/1996WO1996008571A1 Identification of dna-damaging substances by means of cell lines capable of overexpressing poly(adp-ribose)-polymerase
03/21/1996WO1996008570A1 Expression and export technology of proteins as immunofusins
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008557A1 Human inositol monophosphatase h1
03/21/1996WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008512A1 POLYPEPTIDES WITH Fc BINDING ABILITY
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996005309A3 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/21/1996DE4433130A1 Identifizierung von DNA-schädigenden Substanzen durch Poly(ADP-Ribose)-Polymerase überexprimierende Zellinien Identification of DNA-damaging substances by poly (ADP-ribose) polymerase-overexpressing cell lines
03/21/1996DE4426315C1 Membran zur Regeneration von Körpergeweben und Verwendung der Membran als Wundabdeckung und Hautersatz Membrane for the regeneration of body tissues and use of the membrane as a wound covering and skin substitutes
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2199820A1 Modulation of drug radiation resistant genes
03/21/1996CA2198248A1 Polypeptides with fc binding ability
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702082A1 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and dna base sequences encoding those sequences
03/20/1996EP0702081A2 Matrix for tissue culture, method for culturing tissue, method for fixing cultured tissue and artificial skin fixed
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701628A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
03/20/1996EP0701618A1 Method of improving the quality of stored potatoes
03/20/1996EP0701614A1 Putrescine n-methyltransferase, recombinant dna molecules encoding putrescine n-methyltransferase, and transgenic tobacco plants with decreased alkaloid content
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701610A1 Dna coding for the human thyrotropin-releasing hormone receptor
03/20/1996EP0701608A1 Embryonic stem cells for making chimeric and transgenic ungulates
03/20/1996EP0701604A1 Immortalization of denditric cells with v-myc oncogene
03/20/1996EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host
03/20/1996EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/20/1996EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996CN1119028A Process for producing taxane diterpene and method of harvesting cultred cell capable of producing taxane diterpene in high yield
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1118983A Tomato spotted wilt virus
03/19/1996US5500412 Selective stimulation and inhibition of receptor signals, wound healing, antitumor agents
03/19/1996US5500367 Stilbene synthase genes from grapevine
03/19/1996US5500365 Synthetic plant genes
03/19/1996US5500360 RNA transformation vector
03/19/1996US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators
03/19/1996US5500315 An article comprising an image pattern on a substrate
03/19/1996US5500229 Colostrum fraction, a process of preparing it and its use as a supplement in cell culture media
03/14/1996WO1996007750A1 Methods for calcium phosphate transfection
03/14/1996WO1996007749A2 Methods and compositions for inhibiting production of replication competent virus
03/14/1996WO1996007747A1 Retroviral vector hybrids and the use thereof for gene transfer
03/14/1996WO1996007746A1 Acetohydroxyacid synthase promoter expression of introduced genes in plants
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007733A1 Preparation of immortalized cells
03/14/1996WO1996007732A1 Totipotent cells for nuclear transfer
03/14/1996WO1996007730A2 Chemical process for promoting the proliferation of animal cells
03/14/1996WO1996007729A1 Angiopolar cell support and process for producing it
03/14/1996WO1996007433A1 Gene therapy drug for cancer, medicinal composition, and therapeutic method
03/14/1996WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996WO1996006175A3 Fumonisin-detoxifying enzymes
03/14/1996WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins
03/14/1996WO1996005307A3 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1995034667A3 Transformation of guar
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199419A1 Methods and compositions for inhibiting production of replication competent virus
03/14/1996CA2199377A1 Preparation of immortalized cells
03/14/1996CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996CA2197888A1 Modified human c3 proteins
03/13/1996EP0701130A2 Device and process for cell capture and recovery
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700996A1 RNA catalyst for cleaving specific RNA sequences
03/13/1996EP0700994A1 Anti-igf-i monoclonal antibody
03/13/1996EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma
03/13/1996EP0700522A1 Method for selection of biologically active peptide sequences
03/13/1996EP0700446A1 Antibodies specific for dcc gene product
03/13/1996EP0700443A1 Cho cell sialidase disrupted by recombinant dna technology
03/13/1996EP0700442A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700435A1 Transgenic mammals lacking expression of particular cd45 isoforms
03/13/1996EP0700434A1 Novel process and apparatus
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700429A1 Retinal pigment epithelium transplantation
03/13/1996EP0700401A1 Human calcium sensor
03/13/1996EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
03/13/1996EP0700297A1 Surrogate tolerogenesis for the development of tolerance to xenografts
03/13/1996EP0546144B1 Heat-sterilisable porous substrate for bio-catalysts
1 ... 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 ... 1827